Lineage Cell Therapeutics logo

Lineage Cell Therapeutics

A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.

33 employees · est. 1990 · Carlsbad, United States

VS
Promethera Biosciences logo

Promethera Biosciences

Innovative biopharmaceuticals harnessing healthy human liver cells to treat liver diseases with groundbreaking stem cell technology.

11-50 employees · est. 2009

Lineage Cell Therapeutics is the older company (1990 vs 2009).

Side-by-Side Comparison

Lineage Cell Therapeutics Promethera Biosciences
Founded
1990 older 2009
Headquarters
Carlsbad, United States Not tracked yet
Employees
33 11-50
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage
Post Ipo Equity Series D
Total Funding
Not tracked yet $131.06M
Funding Rounds
13 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cell Therapies, Clinical-stage, Regenerative Medicine, Age-related Degenerative Disease, Ophthalmology, Oncology, Spinal Cord Injuries, Vascular Disease, Cancer Immunotherapy, Diagnostics, Cell Delivery Devices, Stem Cell Research, FDA-approved Products Biopharmaceuticals, Cell Therapy, Liver Diseases, Stem Cell Technology, Regenerative Medicine, Chronic Liver Disease, NASH, ACLF, Fatty Liver, Clinical Stage, Liver-based Genetic Diseases, Innovative Treatments, Acquired Liver Diseases, Antibodies
Website
lineagecell.com promethera.com
Lineage Cell Therapeutics logo

About Lineage Cell Therapeutics

Lineage Cell Therapeutics is a clinical-stage biotechnology company focused on developing novel cell therapies to address unmet medical needs. The company's proprietary cell-based therapy platform and associated development and manufacturing capabilities enable it to produce specialized, terminally-...

Promethera Biosciences logo

About Promethera Biosciences

Promethera Biosciences is a biopharmaceutical firm founded in 2009 with a mission to harness healthy human liver cells to develop innovative treatments for liver diseases. The company, originating from the Université Catholique de Louvain, focuses on crafting advanced treatments utilizing allogeneic...

We will tell you when either one moves

BounceWatch watches Lineage Cell Therapeutics and Promethera Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Lineage Cell Therapeut... and Promethera Biosciences — by email.

Frequently Asked Questions

Lineage Cell Therapeutics — A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. . Promethera Biosciences — Innovative biopharmaceuticals harnessing healthy human liver cells to treat liver diseases with groundbreaking stem cell technology.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Lineage Cell Therapeutics has raised undisclosed funding while Promethera Biosciences has raised $131.06M.
Lineage Cell Therapeutics and Promethera Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Lineage Cell Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Lineage Cell Therapeutics on 16 Nov 2024, and Promethera Biosciences on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes